PharVision Advisers’s Sonos SONO Stock Holding History

PharVision Advisers’s Portfolio SONO Stock Details SONO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,192	Closed	-$460K	–	568
2025 Q4	$460K	Buy	26,192 +5,663	+28%	+$98.7K	0.23%	61
2025 Q3	$324K	Buy	+20,529	New	+$263K	0.18%	185

Other funds holding SONO

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's SONO Position: Q1 2026 in Review

PharVision Advisers sold out of Sonos (SONO) in Q1 2026, closing a stake of 26,192 shares — an estimated $460K sold.

PharVision Advisers first reported a position in SONO in Q3 2025 and held it in 2 quarters. The position peaked at $460K in Q4 2025. 291 funds tracked by Wall St. Rank hold SONO as of Q1 2026.

PharVision Advisers reported no remaining Sonos position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 26,192 Sonos shares in Q1 2026, an estimated $460K.
PharVision Advisers first reported a position in Sonos in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Sonos position peaked at $460K in Q4 2025.
291 funds tracked by Wall St. Rank held Sonos as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.